NPO Petrovax Pharm LLC   Report issue

For profit Phase 3
Founded: Moscow Russian Federation (1996)

Organization Overview

First Clinical Trial
2016
NCT03849560
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

NPO Petrovax